Fentiazac

Fentiazac

SCHEMBL16196751

O=C(O)Cc1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1.O=C(O)Cc1sc(-c2ccccc2)nc1-c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 17/20 1.00
KDM4E B2RXH2 4/20 1.00
ALDH1A1 P00352 3/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2C9 P11712 1/20 1.00
HPGD P15428 1/20 1.00
CYP2C19 P33261 1/20 1.00
POLB P06746 1/20 0.83
MEN1 O00255 1/20 0.71
MAPT P10636 1/20 0.71
KMT2A Q03164 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
RXFP1 Q9HBX9 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fentiazac SCHEMBL24355 1.00 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL1514667 1.00 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
Fentiazac SCHEMBL5390943 0.99 PTGDR2 (0.97) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL4497493 0.91 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL11100736 0.90 PTGDR2 (0.82) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL13116312 0.89 PTGDR2 (0.81) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL12608906 0.89 PTGDR2 (0.81) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL5210404 0.86 PTGDR2 (0.76) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL2818129 0.86 PTGDR2 (1.00) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9
SCHEMBL13116322 0.85 PTGDR2 (0.74) PTGDR2KDM4EALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014172776-A1 COMPOUNDS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSES THE HOSPITAL FOR SICK CHILDREN (CA) 2014-10-30 WO disclosed